Norinchukin Bank’s AbbVie ABBV Stock Holding History

Norinchukin Bank’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$23.5M	Buy	108,035 +50	+0%	+$11.1K	0.27%	59
2025 Q4	$24.7M	Buy	107,985 +7,048	+7%	+$1.61M	0.29%	54
2025 Q3	$23.4M	Buy	100,937 +2,031	+2%	+$414K	0.31%	53
2025 Q2	$18.4M	Buy	98,906 +6,911	+8%	+$1.28M	0.27%	59
2025 Q1	$19.3M	Buy	91,995 +12,179	+15%	+$2.37M	0.35%	52
2024 Q4	$14.2M	Buy	79,816 +6,893	+9%	+$1.27M	0.3%	52
2024 Q3	$14.4M	Buy	72,923 +10,347	+17%	+$1.93M	0.34%	51
2024 Q2	$10.7M	Buy	62,576 +718	+1%	+$119K	0.31%	54
2024 Q1	$11.3M	Sell	61,858 -859	-1%	-$148K	0.34%	51
2023 Q4	$9.72M	Sell	62,717 -7,175	-10%	-$1.05M	0.23%	60
2023 Q3	$10.4M	Sell	69,892 -89,080	-56%	-$13.1M	0.24%	58
2023 Q2	$21.4M	Buy	158,972 +44,115	+38%	+$6.47M	0.36%	49
2023 Q1	$18.3M	Buy	114,857 +3,443	+3%	+$526K	0.36%	50
2022 Q4	$18M	Sell	111,414 -27,437	-20%	-$4.21M	0.39%	45
2022 Q3	$18.6M	Buy	138,851 +16,104	+13%	+$2.31M	0.38%	49
2022 Q2	$18.8M	Sell	122,747 -41,698	-25%	-$6.37M	0.37%	47
2022 Q1	$26.7M	Buy	164,445 +12,822	+8%	+$1.86M	0.36%	47
2021 Q4	$20.5M	Sell	151,623 -857	-0.6%	-$101K	0.26%	69
2021 Q3	$16.4M	Buy	152,480 +6,337	+4%	+$724K	0.23%	76
2021 Q2	$16.5M	Sell	146,143 -783	-0.5%	-$88.2K	0.24%	71
2021 Q1	$15.9M	Buy	146,926 +2,434	+2%	+$260K	0.22%	70
2020 Q4	$15.5M	Sell	144,492 -4,365	-3%	-$419K	0.22%	67
2020 Q3	$13M	Buy	148,857 +1,729	+1%	+$163K	0.21%	65
2020 Q2	$14.4M	Buy	147,128 +21,954	+18%	+$1.93M	0.25%	63
2020 Q1	$9.54M	Sell	125,174 -115,160	-48%	-$9.81M	0.19%	77
2019 Q4	$21.3M	Sell	240,334 -17,741	-7%	-$1.47M	0.28%	63
2019 Q3	$19.5M	Buy	258,075 +5,654	+2%	+$388K	0.28%	59
2019 Q2	$18.4M	Sell	252,421 -103,433	-29%	-$8.13M	0.28%	56
2019 Q1	$28.7M	Buy	355,854 +3,277	+0.9%	+$268K	0.37%	52
2018 Q4	$32.5M	Buy	352,577 +80,478	+30%	+$7.08M	0.45%	39
2018 Q3	$25.7M	Buy	272,099 +22,757	+9%	+$2.16M	0.35%	48
2018 Q2	$23.1M	Buy	249,342 +21,257	+9%	+$2.08M	0.34%	47
2018 Q1	$21.6M	Buy	228,085 +19,296	+9%	+$2.12M	0.36%	47
2017 Q4	$20.2M	Sell	208,789 -15,837	-7%	-$1.49M	0.35%	46
2017 Q3	$20M	Buy	224,626 +6,457	+3%	+$492K	0.39%	42
2017 Q2	$15.8M	Buy	218,169 +5,999	+3%	+$403K	0.33%	45
2017 Q1	$13.8M	Buy	212,170 +6,266	+3%	+$394K	0.3%	51
2016 Q4	$12.9M	Buy	205,904 +14,001	+7%	+$855K	0.3%	49
2016 Q3	$12.1M	Sell	191,903 -21,456	-10%	-$1.39M	0.29%	59
2016 Q2	$13.2M	Sell	213,359 -4,166	-2%	-$254K	0.32%	51
2016 Q1	$12.4M	Sell	217,525 -1,016	-0.5%	-$56.6K	0.3%	54
2015 Q4	$12.9M	Buy	218,541 +40,738	+23%	+$2.35M	0.33%	46
2015 Q3	$9.67M	Sell	177,803 -5,798	-3%	-$377K	0.25%	62
2015 Q2	$12.3M	Buy	183,601 +9,485	+5%	+$619K	0.31%	47
2015 Q1	$10.2M	Sell	174,116 -1,379	-0.8%	-$83.3K	0.25%	58
2014 Q4	$11.5M	Buy	175,495 +30,539	+21%	+$1.93M	0.28%	53
2014 Q3	$8.37M	Sell	144,956 -5,360	-4%	-$298K	0.24%	53
2014 Q2	$8.48M	Sell	150,316 -16,790	-10%	-$881K	0.25%	49
2014 Q1	$8.59M	Buy	167,106 +15,583	+10%	+$788K	0.24%	53
2013 Q4	$8M	Sell	151,523 -116	-0.1%	-$5.7K	0.22%	55
2013 Q3	$6.78M	Buy	151,639 +5,147	+4%	+$228K	0.19%	55
2013 Q2	$6.06M	Buy	+146,492	New	+$6.41M	0.18%	55

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norinchukin Bank's ABBV Position: Q1 2026 in Review

Norinchukin Bank increased its AbbVie (ABBV) stake by 0.05% in Q1 2026, buying an estimated $11.1K and bringing the position to 108,035 shares worth $23.5M. The position accounts for 0.27% of the portfolio, ranked #59.

Norinchukin Bank first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $32.5M in Q4 2018. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Norinchukin Bank held 108,035 shares of AbbVie worth $23.5M as of Q1 2026.
Norinchukin Bank bought 50 AbbVie shares in Q1 2026, an estimated $11.1K.
AbbVie made up 0.27% of Norinchukin Bank's portfolio in Q1 2026, its #59 holding.
Norinchukin Bank first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Norinchukin Bank's AbbVie position peaked at $32.5M in Q4 2018.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Norinchukin Bank's 13F filing for Q1 2026, filed 15 May 2026.